Jacek L. Mostwin, M.D., D.Phil.
Jacek L. Mostwin, M.D., D. Phil., is a professor of urology and director of the division of neurological and reconstructive urology at the James Buchanan Brady Urological Institute at Johns Hopkins Medicine in Baltimore. A urological surgeon at Johns Hopkins, he focuses on prostate cancer and has performed more than 3,000 radical prostatectomies. Among his major research interests are urinary continence and bladder function. Most of his scientific publications have dealt with lower urinary tract problems.
Latest by Jacek L. Mostwin, M.D., D.Phil.
If you have recently been diagnosed with prostate cancer, here’s why you should think twice before considering high intensity focused ultrasound.
Learn about the improvements that have been made in external beam radiation therapy for prostate cancer over the past 100 years.
If you’ve had your prostate surgically removed, your penis may be shorter after the procedure. A new study suggests it should go back to regular size in a year.
Prostate cancer can send your life into a tailspin. Here's how to find an oncologist who focuses on prostate cancer to make sure you get the best treatment.
These new therapies for advanced prostate cancer can extend survival and also improve quality of life for patients.
Learn the four key components for prostate cancer prevention.
If you have prostate cancer and you’ve exhausted all the standard treatment options, you may want to join a clinical trial. Here's what you should know.
Findings from a clinical trial suggest that avoiding traditional therapies for early prostate cancer is often a sensible decision.
Proton beam therapy is advertised as the next big thing in prostate cancer treatment, but the evidence doesn't support the hype. Here's what you should know.
If you are diagnosed with prostate cancer, here’s what you should know about picking the right surgeon.